The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with penbutolol.


The risk or severity of adverse effects can be increased when bromazepam is combined with Halazepam.


The risk or severity of adverse effects can be increased when Prasugrel is combined with mesalamine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with etizolam.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Avanafil.


The risk or severity of adverse effects can be increased when clorazepate is combined with clomipramine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when diclofenac is combined with epirizole.


The risk or severity of adverse effects can be increased when Olmesartan is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with pentazocine.


The risk or severity of adverse effects can be increased when brotizolam is combined with promethazine.


The risk or severity of adverse effects can be increased when brotizolam is combined with clonazepam.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when diclofenac is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when trimetrexate is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when butorphanol is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Pramocaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when reserpine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when diclofenac is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when halothane is combined with tiagabine.


The risk or severity of adverse effects can be increased when enflurane is combined with Desloratadine.


The risk or severity of adverse effects can be increased when halothane is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when ketamine is combined with baclofen.


The risk or severity of adverse effects can be increased when ketamine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when sulfisoxazole is combined with mecamylamine.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when theophylline is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with fenoprofen.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with vinblastine.


The risk or severity of adverse effects can be increased when cilostazol is combined with Olsalazine.


The risk or severity of adverse effects can be increased when azelastine is combined with nimesulide.


The risk or severity of adverse effects can be increased when RANOLAZINE is combined with oxycodone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when Escitalopram is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when gabapentin is combined with Perospirone.


The risk or severity of adverse effects can be increased when lithium ion is combined with etizolam.


The risk or severity of adverse effects can be increased when epirizole is combined with haloperidol.


The risk or severity of adverse effects can be increased when misoprostol is combined with Carbetocin.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when benazepril is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with reserpine.


The risk or severity of adverse effects can be increased when oxazepam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when oxazepam is combined with sulpiride.


The risk or severity of adverse effects can be increased when nicergoline is combined with Rilpivirine.


The risk or severity of adverse effects can be increased when morphine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when meprobamate is combined with sevoflurane.


The risk or severity of adverse effects can be increased when bupivacaine is combined with tiapride.


The risk or severity of adverse effects can be increased when Butethal is combined with Fospropofol.


The risk or severity of adverse effects can be increased when bromazepam is combined with Articaine.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with triamcinolone.


The risk or severity of adverse effects can be increased when meprobamate is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when Nelarabine is combined with clozapine.


The risk or severity of adverse effects can be increased when methazolamide is combined with terazosin.


The risk or severity of adverse effects can be increased when terbutaline is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when pentazocine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when pentazocine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when topiramate is combined with paroxetine.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with Mirabegron.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when morniflumate is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when thiamylal is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when midazolam is combined with perphenazine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Halazepam is combined with tizanidine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with apomorphine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Olmesartan.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with topiramate.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with isradipine.


The risk or severity of adverse effects can be increased when PENTAERYTHRITOL TETRANITRATE is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when valsartan is combined with salicylamide.


The risk or severity of adverse effects can be increased when flurazepam is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when reserpine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when prazosin is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Olopatadine is combined with paroxetine.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with promethazine.


The risk or severity of adverse effects can be increased when loxapine is combined with trimipramine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with haloperidol.


The risk or severity of adverse effects can be increased when loxapine is combined with procaine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when tenoxicam is combined with sulindac.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when triazolam is combined with benzocaine.


The risk or severity of adverse effects can be increased when nicardipine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when triazolam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Agomelatine is combined with loratadine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with imipramine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with thiothixene.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when mesalamine is combined with budesonide.


The risk or severity of adverse effects can be increased when morniflumate is combined with celecoxib.


The risk or severity of adverse effects can be increased when codeine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Droxicam is combined with difluprednate.


The risk or severity of adverse effects can be increased when buspirone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Droxicam is combined with halcinonide.


The risk or severity of adverse effects can be increased when Telaprevir is combined with flecainide.


The risk or severity of adverse effects can be increased when Torasemide is combined with digitoxin.


The risk or severity of adverse effects can be increased when mecamylamine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when methyldopa is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Torasemide is combined with metrizamide.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Olopatadine.


The risk or severity of adverse effects can be increased when lithium ion is combined with felbamate.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when ATROPINE is combined with cyclopentolate.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when amisulpride is combined with tetracaine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with scopolamine.


The risk or severity of adverse effects can be increased when prilocaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with triprolidine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when trimeprazine is combined with paroxetine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with clomipramine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with methylphenidate.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with triprolidine.


The risk or severity of adverse effects can be increased when lithium ion is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with methylergonovine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with methylphenidate.


The risk or severity of adverse effects can be increased when Caspofungin is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when chloroxine is combined with diltiazem.


The risk or severity of adverse effects can be increased when griseofulvin is combined with xylometazoline.


The risk or severity of adverse effects can be increased when cilazapril is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when maprotiline is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with phenytoin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when sulpiride is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when sulpiride is combined with glutethimide.


The risk or severity of adverse effects can be increased when Phenelzine is combined with furosemide.


The risk or severity of adverse effects can be increased when Phenelzine is combined with tizanidine.


The risk or severity of adverse effects can be increased when ropinirole is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with fluocinonide.


The risk or severity of adverse effects can be increased when Treprostinil is combined with azelastine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Vilanterol.


The risk or severity of adverse effects can be increased when mirtazapine is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when diethylstilbestrol is combined with atorvastatin.


The risk or severity of adverse effects can be increased when thioridazine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with enflurane.


The risk or severity of adverse effects can be increased when antipyrine is combined with Icatibant.


The risk or severity of adverse effects can be increased when propranolol is combined with mecamylamine.


The risk or severity of adverse effects can be increased when nicergoline is combined with cyclosporin A.


The risk or severity of adverse effects can be increased when triazolam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Metipranolol is combined with Riociguat.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when Vecuronium is combined with Tapentadol.


The risk or severity of adverse effects can be increased when gabapentin is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when lidocaine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with methazolamide.


The risk or severity of adverse effects can be increased when tenoxicam is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when ramipril is combined with Bretylium.


The risk or severity of adverse effects can be increased when Carbetocin is combined with clozapine.


The risk or severity of adverse effects can be increased when nefazodone is combined with thiothixene.


The risk or severity of adverse effects can be increased when bromazepam is combined with duloxetine.


The risk or severity of adverse effects can be increased when acebutolol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with amcinonide.


The risk or severity of adverse effects can be increased when meperidine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when biperiden is combined with morphine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with prazepam.


The risk or severity of adverse effects can be increased when efavirenz is combined with fexofenadine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when metaraminol is combined with metaproterenol.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when nicergoline is combined with zafirlukast.


The risk or severity of adverse effects can be increased when oxybutynin is combined with buprenorphine.


The risk or severity of adverse effects can be increased when etodolac is combined with niflumic acid.


The risk or severity of adverse effects can be increased when nicergoline is combined with vincristine.


The risk or severity of adverse effects can be increased when pentamidine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with lidocaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when quetiapine is combined with baclofen.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with thiopental.


The risk or severity of adverse effects can be increased when mesalamine is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when benztropine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when ketamine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when scopolamine is combined with primidone.


The risk or severity of adverse effects can be increased when cabergoline is combined with bicalutamide.


The risk or severity of adverse effects can be increased when dapsone is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when itraconazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Agomelatine.


The risk or severity of adverse effects can be increased when eperisone is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when lidocaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when amobarbital is combined with enflurane.


The risk or severity of adverse effects can be increased when methadone is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when methadone is combined with nalbuphine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with lithium ion.


The risk or severity of adverse effects can be increased when Articaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when Halobetasol is combined with fleroxacin.


The risk or severity of adverse effects can be increased when terbinafine is combined with isradipine.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with dopamine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with protriptyline.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with efavirenz.


The risk or severity of adverse effects can be increased when Tolcapone is combined with primidone.


The risk or severity of adverse effects can be increased when Caspofungin is combined with Amrinone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when enflurane is combined with Escitalopram.


The risk or severity of adverse effects can be increased when enflurane is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with decamethonium.


The risk or severity of adverse effects can be increased when barnidipine is combined with methyldopa.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with baclofen.


The risk or severity of adverse effects can be increased when duloxetine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when quetiapine is combined with loratadine.


The risk or severity of adverse effects can be increased when barnidipine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when barnidipine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when thiamylal is combined with brotizolam.


The risk or severity of adverse effects can be increased when nimodipine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with metolazone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Erismodegib.


The risk or severity of adverse effects can be increased when imipramine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with rasagiline.


The risk or severity of adverse effects can be increased when Rufinamide is combined with lidocaine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with clemastine.


The risk or severity of adverse effects can be increased when diazepam is combined with levodopa.


The risk or severity of adverse effects can be increased when diazepam is combined with sevoflurane.


The risk or severity of adverse effects can be increased when pirenzepine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when diazepam is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Carbetocin is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when gabapentin is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Olopatadine is combined with loteprednol.


The risk or severity of adverse effects can be increased when mecamylamine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when thiopental is combined with trazodone.


The risk or severity of adverse effects can be increased when desipramine is combined with rasagiline.


The risk or severity of adverse effects can be increased when desipramine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when etodolac is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when mecamylamine is combined with nadolol.


The risk or severity of adverse effects can be increased when thiothixene is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when meperidine is combined with butalbital.


The risk or severity of adverse effects can be increased when buspirone is combined with Fospropofol.


The risk or severity of adverse effects can be increased when halothane is combined with clonidine.


The risk or severity of adverse effects can be increased when ketorolac is combined with triamcinolone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with GLYCEROL PHENYLBUTYRATE.


The risk or severity of adverse effects can be increased when halothane is combined with propranolol.


The risk or severity of adverse effects can be increased when benzoic acid is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when nelfinavir is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when clozapine is combined with tiapride.


The risk or severity of adverse effects can be increased when gabapentin is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when clonazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with brimonidine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Efonidipine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Flupentixol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with clidinium.


The risk or severity of adverse effects can be increased when reserpine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when meprobamate is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when diflunisal is combined with alclofenac.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when levorphanol is combined with estazolam.


The risk or severity of adverse effects can be increased when barnidipine is combined with triamterene.


The risk or severity of adverse effects can be increased when tetracaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when betaxolol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Decitabine is combined with clozapine.


The risk or severity of adverse effects can be increased when indomethacin is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when olanzapine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with mesalamine.


The risk or severity of adverse effects can be increased when lidocaine is combined with Articaine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with paroxetine.


The risk or severity of adverse effects can be increased when thiothixene is combined with procaine.


The risk or severity of adverse effects can be increased when thiothixene is combined with trimipramine.


The risk or severity of adverse effects can be increased when aspirin is combined with Ditazole.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with hydralazine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with antipyrine.


The risk or severity of adverse effects can be increased when trazodone is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with butalbital.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Rilpivirine.


The risk or severity of adverse effects can be increased when itraconazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when linezolid is combined with Cariprazine.


The risk or severity of adverse effects can be increased when levodopa is combined with furazolidone.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Fospropofol.


The risk or severity of adverse effects can be increased when LISURIDE is combined with tamoxifen.


The risk or severity of adverse effects can be increased when ambenonium is combined with Varenicline.


The risk or severity of adverse effects can be increased when Pinaverium is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when tretinoin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when amisulpride is combined with Agomelatine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with losartan.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Sodium oxybate.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with ibuprofen.


The risk or severity of adverse effects can be increased when tacrolimus is combined with cisplatin.


The risk or severity of adverse effects can be increased when morphine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Ezetimibe.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with gabapentin.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when thiopental is combined with dantrolene.


The risk or severity of adverse effects can be increased when methyldopa is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when METYROSINE is combined with promethazine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Articaine.


The risk or severity of adverse effects can be increased when METYROSINE is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when Perospirone is combined with topiramate.


The risk or severity of adverse effects can be increased when quetiapine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when secobarbital is combined with tetracaine.


The risk or severity of adverse effects can be increased when Tramadol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Sacubitril is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with mecamylamine.


The risk or severity of adverse effects can be increased when thiothixene is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when erythromycin is combined with sertraline.


The risk or severity of adverse effects can be increased when thiothixene is combined with baclofen.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when thiothixene is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with pentazocine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with baclofen.


The risk or severity of adverse effects can be increased when tubocurarine is combined with levorphanol.


The risk or severity of adverse effects can be increased when promethazine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when cabergoline is combined with buspirone.


The risk or severity of adverse effects can be increased when butabarbital is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when barnidipine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when haloperidol is combined with Etidocaine.


The risk or severity of adverse effects can be increased when midazolam is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Perospirone is combined with baclofen.


The risk or severity of adverse effects can be increased when disulfiram is combined with ethanol.


The risk or severity of adverse effects can be increased when Articaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Talniflumate is combined with nabumetone.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with oxycodone.


The risk or severity of adverse effects can be increased when Talniflumate is combined with ketorolac.


The risk or severity of adverse effects can be increased when Talniflumate is combined with tenoxicam.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when imipramine is combined with clidinium.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with clozapine.


The risk or severity of adverse effects can be increased when Etomidate is combined with ethosuximide.


The risk or severity of adverse effects can be increased when rasagiline is combined with amisulpride.


The risk or severity of adverse effects can be increased when buprenorphine is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when quazepam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with dyclonine.


The risk or severity of adverse effects can be increased when lorazepam is combined with primidone.


The risk or severity of adverse effects can be increased when Halobetasol is combined with Demecarium.


The risk or severity of adverse effects can be increased when Asenapine is combined with meclizine.


The risk or severity of adverse effects can be increased when carprofen is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when furosemide is combined with hydralazine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Fospropofol is combined with felbamate.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when cetirizine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Butethal is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when ramipril is combined with metoprolol.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Olmesartan.


The risk or severity of adverse effects can be increased when butorphanol is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with glutethimide.


The risk or severity of adverse effects can be increased when primidone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when diflunisal is combined with acetazolamide.


The risk or severity of adverse effects can be increased when butorphanol is combined with benzocaine.


The risk or severity of adverse effects can be increased when Butoconazole is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when triamterene is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Limaprost is combined with clopidogrel.


The risk or severity of adverse effects can be increased when triamterene is combined with Metipranolol.


The risk or severity of adverse effects can be increased when pimozide is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Articaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when promazine is combined with Articaine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with mirtazapine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with acemetacin.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Fospropofol.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with vinorelbine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with clozapine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with acetazolamide.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Olopatadine.


The risk or severity of adverse effects can be increased when nimesulide is combined with triamcinolone.


The risk or severity of adverse effects can be increased when linezolid is combined with lithium ion.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with prilocaine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with efavirenz.


The risk or severity of adverse effects can be increased when Remoxipride is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when rapamycin is combined with nimodipine.


The risk or severity of adverse effects can be increased when paramethasone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when amobarbital is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Perospirone is combined with Articaine.


The risk or severity of adverse effects can be increased when nimodipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with PENTAERYTHRITOL TETRANITRATE.


The risk or severity of adverse effects can be increased when thalidomide is combined with leflunomide.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when pargyline is combined with domperidone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when buspirone is combined with maprotiline.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Posaconazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with pramipexole.


The risk or severity of adverse effects can be increased when Fospropofol is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Telmisartan is combined with captopril.


The risk or severity of adverse effects can be increased when Tianeptine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with acebutolol.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with triamcinolone.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when bepridil is combined with bumetanide.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with clonidine.


The risk or severity of adverse effects can be increased when bepridil is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when docetaxel is combined with norfloxacin.


The risk or severity of adverse effects can be increased when Asenapine is combined with Melatonin.


The risk or severity of adverse effects can be increased when tiapride is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Naftifine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when butorphanol is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when butorphanol is combined with pargyline.


The risk or severity of adverse effects can be increased when buspirone is combined with mesoridazine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Asenapine is combined with clonazepam.


The risk or severity of adverse effects can be increased when diflorasone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when suprofen is combined with nimesulide.


The risk or severity of adverse effects can be increased when efavirenz is combined with clidinium.


The risk or severity of adverse effects can be increased when methocarbamol is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when enalapril is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when fenoprofen is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Pipamperone.


The risk or severity of adverse effects can be increased when ketorolac is combined with fenbufen.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Pralatrexate.


The risk or severity of adverse effects can be increased when ketorolac is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with tiapride.


The risk or severity of adverse effects can be increased when tolmetin is combined with ketoprofen.


The risk or severity of adverse effects can be increased when alprazolam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with scopolamine.


The risk or severity of adverse effects can be increased when carprofen is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Mometasone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when promazine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Micafungin is combined with isradipine.


The risk or severity of adverse effects can be increased when promazine is combined with baclofen.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Masoprocol is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when azelastine is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with spironolactone.


The risk or severity of adverse effects can be increased when aspirin is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Masoprocol is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when metoprolol is combined with penbutolol.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when resveratrol is combined with DESONIDE.


The risk or severity of adverse effects can be increased when bepridil is combined with Carbetocin.


The risk or severity of adverse effects can be increased when dobutamine is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Perospirone.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when promazine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when oxprenolol is combined with efavirenz.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when promazine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when promazine is combined with prazepam.


The risk or severity of adverse effects can be increased when norepinephrine is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when propoxyphene is combined with clonazepam.


The risk or severity of adverse effects can be increased when naratriptan is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when naratriptan is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Difenoxin is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Butoconazole is combined with bepridil.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Melatonin.


The risk or severity of adverse effects can be increased when Normethadone is combined with cetirizine.


The risk or severity of adverse effects can be increased when Normethadone is combined with protriptyline.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with tolazoline.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when methadone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when malathion is combined with nicotine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when triazolam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when halothane is combined with doxepin.


The risk or severity of adverse effects can be increased when irbesartan is combined with fenoprofen.


The risk or severity of adverse effects can be increased when nitrendipine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when salicylamide is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when oxazepam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when salicylamide is combined with prednisone.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Bendamustine is combined with clozapine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with propoxyphene.


The risk or severity of adverse effects can be increased when tacrolimus is combined with cytarabine.


The risk or severity of adverse effects can be increased when sotalol is combined with penbutolol.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with selegiline.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with fluoxetine.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with duloxetine.


The risk or severity of adverse effects can be increased when isoflurane is combined with meclizine.


The risk or severity of adverse effects can be increased when olanzapine is combined with tiagabine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when olanzapine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when HEROIN is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Miltefosine is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with captopril.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with HEROIN.


The risk or severity of adverse effects can be increased when Arotinolol is combined with acebutolol.


The risk or severity of adverse effects can be increased when lidocaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when secobarbital is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when levorphanol is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when Asenapine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when sulindac is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when salicylamide is combined with flunisolide.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with ropinirole.


The risk or severity of adverse effects can be increased when reserpine is combined with doxepin.


The risk or severity of adverse effects can be increased when isoflurane is combined with triazolam.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with dyclonine.


The risk or severity of adverse effects can be increased when Pirlindole is combined with domperidone.


The risk or severity of adverse effects can be increased when ATROPINE is combined with scopolamine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when sulindac is combined with oxaprozin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Deferasirox.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with meclizine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with tetracaine.


The risk or severity of adverse effects can be increased when losartan is combined with Salsalate.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with nitrazepam.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when losartan is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Retigabine.


The risk or severity of adverse effects can be increased when tiapride is combined with Desloratadine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with fluocinonide.


The risk or severity of adverse effects can be increased when lisinopril is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when tenoxicam is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when prilocaine is combined with Articaine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with clemastine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with paramethasone.


The risk or severity of adverse effects can be increased when terconazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when doxylamine is combined with sertraline.


The risk or severity of adverse effects can be increased when ibuprofen is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when amifostine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with olanzapine.


The risk or severity of adverse effects can be increased when Pipotiazine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when loxapine is combined with dibucaine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when flunarizine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when terconazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when triazolam is combined with Asenapine.


The risk or severity of adverse effects can be increased when isoflurane is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when selegiline is combined with papaverine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with pentazocine.


The risk or severity of adverse effects can be increased when Talniflumate is combined with indomethacin.


The risk or severity of adverse effects can be increased when levorphanol is combined with bromazepam.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when levorphanol is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when meclizine is combined with flunarizine.


The risk or severity of adverse effects can be increased when meclizine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when loxapine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with baclofen.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with prazosin.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with loratadine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with penbutolol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with captopril.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with brotizolam.


The risk or severity of adverse effects can be increased when metoclopramide is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when zaleplon is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when triprolidine is combined with desipramine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with imipramine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when niflumic acid is combined with fenbufen.


The risk or severity of adverse effects can be increased when lidocaine is combined with prazepam.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Clofarabine is combined with hydralazine.


The risk or severity of adverse effects can be increased when lidocaine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with benazepril.


The risk or severity of adverse effects can be increased when mesoridazine is combined with clonidine.


The risk or severity of adverse effects can be increased when labetalol is combined with floctafenine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with reserpine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with tolmetin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when METAXALONE is combined with sertraline.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Remoxipride.


The risk or severity of adverse effects can be increased when tioconazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Halazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when testosterone propionate is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Sacubitril is combined with aspirin.


The risk or severity of adverse effects can be increased when mesoridazine is combined with tetracaine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Retigabine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with lithium ion.


The risk or severity of adverse effects can be increased when pramipexole is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with DESONIDE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when procyclidine is combined with cyclopentolate.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when methylergonovine is combined with quinidine.


The risk or severity of adverse effects can be increased when cocaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Salsalate.


The risk or severity of adverse effects can be increased when sevoflurane is combined with etizolam.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with equilin.


The risk or severity of adverse effects can be increased when pargyline is combined with dipivefrin.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with salicylamide.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with glutethimide.


The risk or severity of adverse effects can be increased when cabergoline is combined with linezolid.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when prednisone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when mesalamine is combined with Mometasone.


The risk or severity of adverse effects can be increased when tirofiban is combined with Apixaban.


The risk or severity of adverse effects can be increased when tolterodine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when methoxamine is combined with nylidrin.


The risk or severity of adverse effects can be increased when Icatibant is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Icatibant is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when dyclonine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when celiprolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when clomipramine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when risperidone is combined with triflupromazine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with brimonidine.


The risk or severity of adverse effects can be increased when antipyrine is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Butethal is combined with Milnacipran.


The risk or severity of adverse effects can be increased when apomorphine is combined with selegiline.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with meperidine.


The risk or severity of adverse effects can be increased when zonisamide is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when HEROIN is combined with triprolidine.


The risk or severity of adverse effects can be increased when Dabigatran etexilate is combined with Deferasirox.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when HEROIN is combined with methocarbamol.


The risk or severity of adverse effects can be increased when benztropine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when HEROIN is combined with spironolactone.


The risk or severity of adverse effects can be increased when pimozide is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Masoprocol is combined with formestane.


The risk or severity of adverse effects can be increased when selegiline is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when apomorphine is combined with diltiazem.


The risk or severity of adverse effects can be increased when HEROIN is combined with Mersalyl.


The risk or severity of adverse effects can be increased when prilocaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when amisulpride is combined with clomipramine.


The risk or severity of adverse effects can be increased when temazepam is combined with felbamate.


The risk or severity of adverse effects can be increased when Telaprevir is combined with quinidine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Ramelteon.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with zotepine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with MELPERONE.


The risk or severity of adverse effects can be increased when timolol is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when timolol is combined with furosemide.


The risk or severity of adverse effects can be increased when benazepril is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with theobromine.


The risk or severity of adverse effects can be increased when halothane is combined with Butethal.


The risk or severity of adverse effects can be increased when halothane is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when halothane is combined with lithium ion.


The risk or severity of adverse effects can be increased when MELPERONE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when indapamide is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Etomidate is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with amoxapine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when pimozide is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when MELPERONE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Propacetamol.


The risk or severity of adverse effects can be increased when pimozide is combined with fludiazepam.


The risk or severity of adverse effects can be increased when methylene blue is combined with Vilazodone.


The risk or severity of adverse effects can be increased when Butethal is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with nortriptyline.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with amoxapine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when sotalol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when triazolam is combined with proparacaine.


The risk or severity of adverse effects can be increased when Prasugrel is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when triazolam is combined with Halazepam.


The risk or severity of adverse effects can be increased when cabergoline is combined with Paliperidone.


The risk or severity of adverse effects can be increased when leflunomide is combined with paramethasone.


The risk or severity of adverse effects can be increased when doxepin is combined with formoterol.


The risk or severity of adverse effects can be increased when Icatibant is combined with flumethasone.


The risk or severity of adverse effects can be increased when aspirin is combined with niflumic acid.


The risk or severity of adverse effects can be increased when anagrelide is combined with salicylic acid.


The risk or severity of adverse effects can be increased when flunisolide is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when haloperidol is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when nitric oxide is combined with propofol.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when brotizolam is combined with topiramate.


The risk or severity of adverse effects can be increased when Masoprocol is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when selegiline is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when triamterene is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Iobenguane.


The risk or severity of adverse effects can be increased when Naftifine is combined with antipyrine.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with meperidine.


The risk or severity of adverse effects can be increased when Trospium is combined with morphine.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with barnidipine.


The risk or severity of adverse effects can be increased when Etomidate is combined with felbamate.


The risk or severity of adverse effects can be increased when Rufinamide is combined with risperidone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with meclizine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with fenbufen.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Pixantrone.


The risk or severity of adverse effects can be increased when clonazepam is combined with promethazine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Butethal.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when meperidine is combined with meclizine.


The risk or severity of adverse effects can be increased when meperidine is combined with risperidone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with pancuronium.


The risk or severity of adverse effects can be increased when scopolamine is combined with ethotoin.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with Vecuronium.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when cetirizine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when carbamazepine is combined with butalbital.


The risk or severity of adverse effects can be increased when tolmetin is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Halobetasol.


The risk or severity of adverse effects can be increased when morniflumate is combined with Naftifine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with methocarbamol.


The risk or severity of adverse effects can be increased when indomethacin is combined with estrone.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with triprolidine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with clidinium.


The risk or severity of adverse effects can be increased when morphine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with quetiapine.


The risk or severity of adverse effects can be increased when irbesartan is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when chloramphenicol is combined with clozapine.


The risk or severity of adverse effects can be increased when procaine is combined with Articaine.


The risk or severity of adverse effects can be increased when labetalol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when prilocaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when benzocaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when buspirone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when estazolam is combined with mepivacaine.


The risk or severity of adverse effects can be increased when estazolam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with carprofen.


The risk or severity of adverse effects can be increased when Tavaborole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when butabarbital is combined with halothane.


The risk or severity of adverse effects can be increased when codeine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Icatibant is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Artemether is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Melatonin.


The risk or severity of adverse effects can be increased when imipramine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with carisoprodol.


The risk or severity of adverse effects can be increased when methotrexate is combined with leflunomide.


The risk or severity of adverse effects can be increased when proparacaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when benazepril is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with promethazine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with clonazepam.


The risk or severity of adverse effects can be increased when Eprosartan is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when sulpiride is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with pramipexole.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with imipramine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with loratadine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when diltiazem is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with butamben.


The risk or severity of adverse effects can be increased when Icatibant is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with zonisamide.


The risk or severity of adverse effects can be increased when butabarbital is combined with protriptyline.


The risk or severity of adverse effects can be increased when oxycodone is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when linezolid is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with procarbazine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Asenapine.


The risk or severity of adverse effects can be increased when loratadine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with ofloxacin.


The risk or severity of adverse effects can be increased when phenobarbital is combined with meclizine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Butethal.


The risk or severity of adverse effects can be increased when ethotoin is combined with Iloperidone.


The risk or severity of adverse effects can be increased when demeclocycline is combined with Alitretinoin.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with citric acid.


The risk or severity of adverse effects can be increased when loxapine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when nicergoline is combined with dihydroergotamine.


The risk or severity of adverse effects can be increased when loxapine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when loxapine is combined with amobarbital.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when amitriptyline is combined with clidinium.


The risk or severity of adverse effects can be increased when meprobamate is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with formestane.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Bretylium.


The risk or severity of adverse effects can be increased when doxepin is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when maprotiline is combined with flunarizine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when trandolapril is combined with enalapril.


The risk or severity of adverse effects can be increased when trandolapril is combined with diclofenac.


The risk or severity of adverse effects can be increased when felbamate is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with epinephrine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when azelastine is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with acebutolol.


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with clomipramine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with levorphanol.


The risk or severity of adverse effects can be increased when Rotigotine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when hydroxyurea is combined with leflunomide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with nortriptyline.


The risk or severity of adverse effects can be increased when clozapine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with amoxapine.


The risk or severity of adverse effects can be increased when oxazepam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with nimodipine.


The risk or severity of adverse effects can be increased when clozapine is combined with baclofen.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with sulpiride.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with digoxin.


The risk or severity of adverse effects can be increased when moclobemide is combined with Indacaterol.


The risk or severity of adverse effects can be increased when clozapine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with triprolidine.


The risk or severity of adverse effects can be increased when Ximelagatran is combined with Nintedanib.


The risk or severity of adverse effects can be increased when pimozide is combined with scopolamine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with methocarbamol.


The risk or severity of adverse effects can be increased when nifedipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when pergolide is combined with propofol.


The risk or severity of adverse effects can be increased when Calcium acetate is combined with Calcifediol.


The risk or severity of adverse effects can be increased when doxazosin is combined with quinapril.


The risk or severity of adverse effects can be increased when doxazosin is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with cabergoline.


The risk or severity of adverse effects can be increased when Riociguat is combined with Aliskiren.


The risk or severity of adverse effects can be increased when doxazosin is combined with bumetanide.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with ethosuximide.


The risk or severity of adverse effects can be increased when ibudilast is combined with Olsalazine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with butalbital.


The risk or severity of adverse effects can be increased when terbutaline is combined with dopamine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when gabapentin is combined with fluoxetine.


The risk or severity of adverse effects can be increased when gabapentin is combined with duloxetine.


The risk or severity of adverse effects can be increased when ondansetron is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with fludiazepam.


The risk or severity of adverse effects can be increased when bupivacaine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when isoflurane is combined with irbesartan.


The risk or severity of adverse effects can be increased when Rufinamide is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when oxazepam is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when lithium ion is combined with clonidine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with triazolam.


The risk or severity of adverse effects can be increased when haloperidol is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when citalopram is combined with Flupentixol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Sacubitril is combined with reserpine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with nisoldipine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with tetracaine.


The risk or severity of adverse effects can be increased when tiagabine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when ramipril is combined with ketoprofen.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with etodolac.


The risk or severity of adverse effects can be increased when tiagabine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Imatinib.


The risk or severity of adverse effects can be increased when loratadine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Clofarabine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when levorphanol is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when clozapine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when clozapine is combined with procaine.


The risk or severity of adverse effects can be increased when clozapine is combined with lisinopril.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with maprotiline.


The risk or severity of adverse effects can be increased when midazolam is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Naftifine.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with malathion.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with dobutamine.


The risk or severity of adverse effects can be increased when METYROSINE is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when meperidine is combined with flunarizine.


The risk or severity of adverse effects can be increased when meperidine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when meperidine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when nefazodone is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with HEROIN.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with DESONIDE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when methadone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when methadone is combined with bromocriptine.


The risk or severity of adverse effects can be increased when formestane is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when rescinnamine is combined with leflunomide.


The risk or severity of adverse effects can be increased when ondansetron is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Melatonin is combined with Perospirone.


The risk or severity of adverse effects can be increased when epoprostenol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when bumetanide is combined with ouabain.


The risk or severity of adverse effects can be increased when Tiotropium is combined with propoxyphene.


The risk or severity of adverse effects can be increased when dapsone is combined with mafenide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with thiamylal.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when quetiapine is combined with amobarbital.


The risk or severity of adverse effects can be increased when methocarbamol is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when benztropine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Clofarabine is combined with felodipine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Aclidinium is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with halothane.


The risk or severity of adverse effects can be increased when nitrendipine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when ethotoin is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Difenoxin.


The risk or severity of adverse effects can be increased when midazolam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when midazolam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with cilazapril.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with thiamylal.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with sulpiride.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with amoxapine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with carisoprodol.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Clofarabine is combined with irbesartan.


The risk or severity of adverse effects can be increased when alprazolam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when cerulenin is combined with Pregabalin.


The risk or severity of adverse effects can be increased when nicergoline is combined with epinephrine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with nadolol.


The risk or severity of adverse effects can be increased when niflumic acid is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when protriptyline is combined with sumatriptan.


The risk or severity of adverse effects can be increased when niflumic acid is combined with prednisone.


The risk or severity of adverse effects can be increased when Articaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Dapagliflozin is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when morphine is combined with felodipine.